TAK1-IN-4
TAK1-IN-4 (Compound 14) is a TAK1 inhibitor[1].
Product Specifications
CAS Number
[1570374-32-1]
UNSPSC
12352005
Target
MAP3K
Type
Reference compound
Related Pathways
MAPK/ERK Pathway
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/tak1-in-4.html
Concentration
10mM
Purity
99.30
Solubility
DMSO : 83.33 mg/mL (ultrasonic)
Smiles
O=C(C1=CC=CC(C(NC2=NC3=C(N2CCC)C=CC=C3)=O)=C1)O
Molecular Formula
C18H17N3O3
Molecular Weight
323.35
References & Citations
[1]Emily Derbyshire, et al. Novel inhibitors of transforming growth factor kinase and methods of use thereof. Patent US20180105500A1.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
MAP3K7/TAK1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15330076 1 Vial
Lentiviral human BTBD11 shRNA (UAS) - Lentiviral human BTBD11 shRNA (UAS, RFP) plasmid
Ask
View Details 